Proposed BIOSECURE Act Targets Chinese Biotech Firms - Could Disrupt Life Sciences Supply Chains in the Federal Sector
The U.S. House of Representatives and the U.S. Senate are advancing a new bill the BIOSECURE Act (H.R. 8333i and S. 3558ii) that would (i) prohibit the U.S. Government from contracting with "biotechnology companies of concern"iii and (ii) …